Related Experiment Video
Updated: Jun 29, 2026

06:53
An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense
Published on: April 17, 2026
Candida parapsilosis, an emerging fungal pathogen
David Trofa1, Attila Gácser, Joshua D Nosanchuk
1Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Clinical Microbiology Reviews
|October 16, 2008
Summary
Candida parapsilosis is a growing cause of invasive infections, particularly in neonates and ICU patients. Understanding its virulence factors is key to developing new treatments for this emerging pathogen.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Candida parapsilosis has emerged as a significant human pathogen over the last two decades.
- It is now a leading cause of invasive candidal disease, especially in vulnerable populations.
Purpose of the Study:
- To summarize the increasing prevalence and clinical significance of Candida parapsilosis infections.
- To review the risk factors, pathogenesis, and emerging research on virulence.
Main Methods:
- Review of epidemiological data and clinical case studies.
- Analysis of factors contributing to Candida parapsilosis pathogenesis.
- Discussion of advancements in molecular genetic tools for virulence studies.
Main Results:
- Candida parapsilosis infections are associated with hyperalimentation, medical devices, and healthcare worker transmission.
- Key virulence factors include enzyme secretion, adhesion to prosthetics, and biofilm formation.
- Neonates and intensive care unit (ICU) patients are at the highest risk.
Conclusions:
- Candida parapsilosis is a major and increasing threat in healthcare settings.
- Further understanding of its pathogenesis through molecular tools will aid in developing novel therapies.
- Effective management requires addressing nosocomial spread and host-specific vulnerabilities.
Related Concept Videos
Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Fungal Phylum Ascomycota
Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Fungal Group Zygomycota
Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
